MedTrace Logo

The Role of Serum Anticholinergic Activity in ACVB Patients

NCT00782938 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2010-01-14

No results posted yet for this study

Summary

Drugs with anticholinergic potential increase the risk of postoperative transient and persistent cognitive dysfunction especially in cardiac patients. The investigators main goal is to identify preoperative risk factors and to monitor postoperative patients' state in relation to SAA activity and bilateral BIS-EEG changes.

Conditions

  • Acetylcholine
  • Cognition
  • BIS-EEG

Sponsors & Collaborators

  • Heidelberg University

    lead OTHER

Principal Investigators

  • Eike Martin, Prof. · Department of Anesthesiology, University of Heidelberg

Eligibility

Min Age
55 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2009-12-31
Completion
2010-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00782938 on ClinicalTrials.gov